Study the effect of Nagaradi Kwath eye drops in Kaphaj Abhishyanda that is Acute Mucopurulant Conjunctivitis.

A Clinical Study to assess The Efficacy Of Nagaradi Kwath Aschotan in Kaphaj Abhishyanda w. s. r. to Acute Mucopurulant Conjunctivitis.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021693

Enrollment

100

Registered

2019-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

Intervention1: NA: NA Intervention2: NAGARADI KWATH EYE DROPS: Nagaradi Kwath contains Nagar, Triphala, Nimba, Vasa and Lodhra. Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Kaphaj Abhishynada.

Exclusion criteria

Exclusion criteria: Patient other than Kaphaj abhishyanda. patients having Kaphaj Abhishyanda with any other major systemic illness. If any type of corneal involvement.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Nagaradi Kwath Aschotan in Kaphaj Abhishyanda patients.Timepoint: 3rd, 5th, 7th, 10th days for trial medication, observations and 15th day for observation only. Total study duration is of 2 years.	—

Secondary

Measure	Time frame
To evaluate the effect of Nagaradi kwath Aschotan to prevent deterioration in patients of kaphaj abhishyanda. To sudy and compare the sign and symptoms of Kaphaj Abhishyanda with modern science disease. To find out irritation and results of the trial drug in conjunctiva of Rabbit Model. To find out cost effectiveness of the treatment. To see the Adverse effects of the drug if any. Timepoint: 3rd, 5th, 7th, 10th days for trial medication, observations and 15th day for observation only. Total study duration is of 2 years.	—

Measure

Time frame

To evaluate the effect of Nagaradi kwath Aschotan to prevent deterioration in patients of kaphaj abhishyanda. To sudy and compare the sign and symptoms of Kaphaj Abhishyanda with modern science disease. To find out irritation and results of the trial drug in conjunctiva of Rabbit Model. To find out cost effectiveness of the treatment. To see the Adverse effects of the drug if any. Timepoint: 3rd, 5th, 7th, 10th days for trial medication, observations and 15th day for observation only. Total study duration is of 2 years.

—

Countries

India

Contacts

Public ContactDR PRAVIN VITTHAL CHAVAN

YASHWANT AYURVED MAHAVIDAYAYA

drcnm05@gmail.com9175800710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026